Table 3.

Comparison of the number of HIV‐positive pregnant women and HEI receiving PMTCT and EID services in 15 ODs before and after implementation of IACM

	Identified HIV ‐positive PW	HIV‐positive PW receiving ART/ARV proph (%)	HEI born	HEI received ARV (%)	HEI received Cotrim (%)	HEI received DNA‐PCR test (%)	DNA‐PCR positive result (%)
Before IACM Approach 2011 to 2013	1273	921 (72.3)	995	952 (95.7)	414 (41.6)a	410 (41.2)a	10 (2.4)
After IACM Approach 2014 to 2016	938	867 (92.4)	533	456 (85.6)	390 (73.2)a	396 (74.3)a	7 (1.8)
p‐valueb	‐	p < 0001	‐	p < 0001	p < 0001	p < 0001	p = 0.5073

ART, antiretroviral therapy; ARV proph, antiretroviral prophylaxis; HEI, HIV exposed infants; PW, pregnant women.

^aCalculated using HEI born as denominator (as only data available for both period before and after IACM approach); ^bchi square test was used.